Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
12/19/1990 | EP0402354A1 Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine |
12/19/1990 | CN1047884A Hepatitis a attenuation living vaccine (h2 attenuation strains) and preparation thereof |
12/19/1990 | CA2019217A1 Magnetic protein conjugates, a process for the preparation thereof and the use thereof |
12/18/1990 | US4978745 Immunoreactive heterochain antibodies |
12/18/1990 | US4978622 Cytophaga-derived immunopotentiator |
12/18/1990 | US4978621 Merozoite surface antigens |
12/18/1990 | US4978609 Monoclonal antibody specific to human pancreatic phospholipase A2 |
12/18/1990 | US4978520 Injecting antibodies, biofiltration, recovering filtered antibodies |
12/18/1990 | CA1277934C Hybrid cells producing an antibody characteristic of the hepatitis b virus from hepatocytes and established cells of monkey, process for obtaining such hybrid cells and application thereof for the production of the antigens aforementioned |
12/17/1990 | WO1990015808A1 Radionuclide metal chelates for the radiolabeling of proteins |
12/16/1990 | WO1990015878A1 Immunoactive peptides and antibodies and their use in anti-allergy treatment |
12/16/1990 | WO1990015870A1 Interleukin-7 receptors |
12/16/1990 | WO1990015596A1 Glucan drug delivery system and adjuvant |
12/16/1990 | CA2059275A1 Glucan drug delivery system and adjuvant |
12/16/1990 | CA2033082A1 Interleukin-7 receptors |
12/15/1990 | WO1990015622A1 Method of preparing vaccines against rna viruses |
12/14/1990 | WO1990015820A1 Peptides and antibodies derived therefrom for the diagnosis of, therapy for and vaccination against htlv-1 infection |
12/14/1990 | CA2062713A1 Peptides and antibodies derived therefrom for the diagnosis of, therapy for and vaccination against htlv-1 infection |
12/13/1990 | WO1990015158A1 Nucleotide sequences for the amplification of the hiv-2 and siv type retrovirus genome, and their applications in in vitro diagnosis of infections caused by these viruses |
12/13/1990 | WO1990015152A1 Monoclonal antibodies for inducing tolerance |
12/13/1990 | WO1990015141A2 Self-assembled, defective, non-self-propagating viral particles |
12/13/1990 | WO1990015133A1 Method of producing core structure of retro virus and particle produced thereby |
12/13/1990 | WO1990015132A2 Cloned treponema hyodysenteriae endoflagellar antigen |
12/13/1990 | WO1990015077A1 Monoclonal antibody specific for bacterial transport proteins, and antibody-containing deodorant composition |
12/13/1990 | WO1990015075A1 HTLV-1 ENV GENE PRODUCTS EXPRESSED IN $i(E. COLI) |
12/13/1990 | WO1990015074A1 Methods for enhancing the rate of modification of metastable bonds |
12/13/1990 | WO1990015066A2 Nucleotidic sequences resulting from the retrovirus gemone of the hiv-1, hiv-2, and siv type, and their applications, in particular for the amplification of the genomes of said retroviruses and for the in vitro diagnosis of infections caused by these viruses |
12/13/1990 | WO1990014881A2 Chelating agents for attaching metal ions to proteins |
12/13/1990 | WO1990014837A1 Adjuvant formulation comprising a submicron oil droplet emulsion |
12/13/1990 | CA2685262A1 Nucleotides sequences derived from the genome of type hiv-1, hiv-2 and siv retroviruses, and their applications especially for the amplification the genomes of these retroviruses and for in vitro diagnosis of infections due to these viruses |
12/13/1990 | CA2033086A1 Chelating agents for attaching metal ions to proteins |
12/12/1990 | EP0402116A1 Proteins, vaccines and nucleic acids |
12/12/1990 | EP0402088A2 Conjugate immunogen for aids |
12/12/1990 | EP0401941A2 Hepatitis B virus surface antigen and production thereof |
12/12/1990 | EP0401421A2 Non-reverting RNA viruses |
12/12/1990 | EP0401347A1 Use of transferrin to combat the toxic effects of endotoxins in endotoxemia. |
12/12/1990 | EP0401248A1 Affinity matrices of modified polysaccharide supports |
12/12/1990 | EP0401247A1 Monoclonal antibody specific to a novel mucin-like glycoprotein surface antigen on human carcinoma cells |
12/11/1990 | US4977092 Expression of exogenous polypeptides and polypeptide products including hepatitis B surface antigen in yeast cells |
12/11/1990 | US4976958 Mycobacterial recombinants and peptides |
12/11/1990 | US4976957 Process for the production of recognins and their chemoreciprocals |
12/11/1990 | CA1277614C Sialylated lewisx epitope, antibodies and diagnosis |
12/11/1990 | CA1277613C Monoclonal antibodies, a process for their preparation and their use |
12/11/1990 | CA1277612C Monoclonal antibodies with specificity for membrane- associated antigens |
12/11/1990 | CA1277600C Tumor therapeutic agent and a process for its preparation |
12/08/1990 | CA2018453A1 Methods for enhancing the rate of modification of metastable bonds |
12/07/1990 | CA2018248A1 Monoclonal antibodies against the human alpha/beta t-cell receptor, their production and use |
12/06/1990 | WO1990015078A1 HUMAN MONOCLONAL ANTIBODIES TO HIV-1MN gp 120 |
12/06/1990 | CA2058630A1 Human monoclonal antibodies to hiv-1 mn gp 120 |
12/06/1990 | CA2018332A1 Proteins, vaccines and nucleic acids |
12/06/1990 | CA2018297A1 Conjugate immunogen for aids |
12/05/1990 | EP0401055A2 Bone Calcification factor |
12/05/1990 | EP0400973A1 Mycobacterial secretory expression vectors and transformants |
12/05/1990 | EP0400958A2 Live vaccines |
12/05/1990 | EP0400762A1 Treating animals using IL-2, formulations therefor and their preparation |
12/05/1990 | EP0400569A2 Method for preparing a vaccine from Streptococcus mutans for dental caries and vaccinal compositions for dental caries used as nasal drops |
12/05/1990 | EP0400464A1 Monoclonal antibody reactive to a unique antigen widely present on various human leukemia and lymphoma cells and methods of using same for diagnosis and treatment |
12/05/1990 | EP0400107A1 Swine dysentery subunit vaccine and method |
12/05/1990 | EP0400077A1 Use of synthetic peptides to generate and manipulate cellular immunity |
12/05/1990 | EP0103605B1 Method for free ligand assays |
12/05/1990 | CN1047531A Hog cholera virus vaccine and diagnostic |
12/04/1990 | WO1990015073A1 Grf peptides |
12/04/1990 | US4975420 Agents and procedures for provoking an immune response to GnRH and immuno sterilizing mammals |
12/04/1990 | US4975369 Recombinant and chimeric KS1/4 antibodies directed against a human adenocarcinoma antigen |
12/04/1990 | CA2055619A1 Grf peptides |
12/04/1990 | CA1277270C Process for the culture of the infectious rhinotracheitis virus, particularlyof the turkey, and vaccine prepared with the virus thus obtained |
12/04/1990 | CA1277262C Antibodies, manufacture and use |
12/04/1990 | CA1277261C Monoclonal antibodies and hybridoma cells, to humain reinin: processes for their preparation and their applications |
12/04/1990 | CA1277260C Monoclonal antibody panel for early diagnosis and therapy of renal carcinoma |
12/04/1990 | CA1277231C Process and reagent for the specific determination of pancreatic -amylase |
12/03/1990 | WO1990015875A1 Protein having a transactivating property, vectors expressing this protein, cell lines, and uses thereof |
12/03/1990 | WO1990015149A1 Vpt protein, vectors expressing this protein, cell products and assay methods |
12/03/1990 | WO1990015076A2 MONOCLONAL ANTIBODIES AGAINST LEUKOCYTE ADHESION RECEPTOR β-CHAIN, METHODS OF PRODUCING THESE ANTIBODIES AND USE THEREFORE |
12/03/1990 | CA2056452A1 Protein having a transactivating property, vectors expressing this protein, cell lines, and uses thereof |
12/03/1990 | CA2055591A1 Vpt protein, vectors expressing this protein, cell products and assay methods |
12/02/1990 | CA2017466A1 Bone calcification factor |
12/01/1990 | WO1990015140A1 Production of ibdv vp2 in highly immunogenic form |
12/01/1990 | WO1990014842A1 Vaccine against hiv |
12/01/1990 | WO1990014835A1 Method to treat rheumatoid arthritis |
12/01/1990 | CA2056450A1 Method to treat rheumatoid arthritis |
12/01/1990 | CA2055616A1 Vaccines |
12/01/1990 | CA2050275A1 Production of ibdv vp2 in highly immunogenic form |
12/01/1990 | CA2017936A1 Htlv-1 env gene products expressed in e. coli |
12/01/1990 | CA2017528A1 Monoclonal antibody reactive to a unique antigen widely present on various human leukemia and lymphoma cells and methods of using same for diagnosis and treatment |
11/29/1990 | WO1990014436A1 Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus |
11/29/1990 | WO1990014427A2 Multivalent repressor of gene function |
11/29/1990 | WO1990014419A1 Human cell line lc5 and its use |
11/29/1990 | WO1990014363A1 Metalloproteinase inhibitor |
11/29/1990 | WO1990014357A1 Her2 extracellular domain |
11/29/1990 | WO1990014351A1 Hematopoietic growth factor derived form t lymphocytes and methods of use therefor |
11/29/1990 | WO1990014104A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
11/29/1990 | WO1990014099A2 Interleukin-2 tn treating birds |
11/29/1990 | WO1990014073A1 Pharmaceutical preparation |
11/29/1990 | CA2054764A1 Hematopoietic growth factor derived form t lymphocytes and methods of use therefor |
11/28/1990 | EP0399843A2 Adjuvant formulation comprising a submicron oil droplet emulsion |
11/28/1990 | EP0399777A2 Hematopoietic growth factor derived from T lymphocytes and methods of use therefor |
11/28/1990 | EP0399257A1 Cell surface antigen that binds with L6 Monoclonal antibody |
11/28/1990 | EP0399184A2 Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassay |
11/28/1990 | EP0399024A1 ANTI-INTERLEUKINE 1$g(a) AND 1$g(b) MONOCLONAL ANTIBODIES, METHOD FOR PRODUCING THE SAME AND APPLICATIONS OF SAID ANTIBODIES TO THE DETECTION OF INTERLEUKINES 1$g(a) AND 1$g(b) AND TO THERAPY |
11/28/1990 | EP0398955A1 Diagnosis of retinoblastoma |